Loading...
Author Verified
RCT
ACE Report #156
Ace Report Cover Arthroplasty

Mobile compression device vs. heparin for prevention of thromboembolic events after THA


Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin

J Bone Joint Surg Am. 2010 Mar;92(3):527-35

Contributing Authors: Colwell CW MI Froimson MA Mont MA Ritter RT Trousdale KC Buehler A Spitzer TK Donaldson DE Padgett

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

OE EXCLUSIVE

Dr. Colwell discusses his study assessing the safety of a mobile compression device for thrombo-prophylaxis.

Synopsis

386 patients (>18 yr) who had been scheduled for 389 total hip arthroplasties were randomized to receive thromboprophylaxis by either a mobile compression device (CECT SFT) or standardly accepted low-molecular-weight heparin (LMWH).The CECT SFT demonstrated effective thromboprophylaxis with a better safety profile (fewer major bleeding events) compared to LMWH.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.